{"id":2512,"date":"2018-11-01T17:38:28","date_gmt":"2018-11-01T18:38:28","guid":{"rendered":"http:\/\/brtfinancial.com\/blog\/dental-practice-funding-more-news-abbvie-roche-combo-treatment-meets-main-goal-of-leukemia-trial\/"},"modified":"2018-11-01T17:38:28","modified_gmt":"2018-11-01T18:38:28","slug":"dental-practice-funding-more-news-abbvie-roche-combo-treatment-meets-main-goal-of-leukemia-trial","status":"publish","type":"post","link":"https:\/\/brtfinancial.com\/blog\/dental-practice-funding-more-news-abbvie-roche-combo-treatment-meets-main-goal-of-leukemia-trial\/","title":{"rendered":"Dental Practice Funding More News: AbbVie, Roche combo treatment meets main goal of leukemia trial"},"content":{"rendered":"<p><a href='' target='_blank'>  <\/a> [ad_1]<br \/>\n\t\t\t\t\t\t\t\t\t<br \/>(This Oct 31 story corrects paragraph one to say targeted therapy, not immunotherapy)<\/p>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/healthNews?a=B6zTgPaGd4o:jhkiQ54Szkk:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/healthNews?d=yIl2AUoC8zA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/healthNews?a=B6zTgPaGd4o:jhkiQ54Szkk:F7zBnMyn0Lo\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/healthNews?i=B6zTgPaGd4o:jhkiQ54Szkk:F7zBnMyn0Lo\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/healthNews?a=B6zTgPaGd4o:jhkiQ54Szkk:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/healthNews?i=B6zTgPaGd4o:jhkiQ54Szkk:V_sGLiPBpWU\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/reuters\/healthNews\/~4\/B6zTgPaGd4o\" height=\"1\" width=\"1\" alt=\"\" \/><br \/>\n\t\t\t\t\t\t\t\t\t<br \/>[ad_2]<br \/>\n\t\t\t\t\t\t\t\t\t<br \/><a href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/B6zTgPaGd4o\/abbvie-roche-combo-treatment-meets-main-goal-of-leukemia-trial-idUSKCN1N530I\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[ad_1] (This Oct 31 story corrects paragraph one to say targeted therapy, not immunotherapy) [ad_2] Source link<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2512","post","type-post","status-publish","format-standard","hentry","category-dental-medical-practice-financing-programs"],"_links":{"self":[{"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/posts\/2512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/comments?post=2512"}],"version-history":[{"count":0,"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/posts\/2512\/revisions"}],"wp:attachment":[{"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/media?parent=2512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/categories?post=2512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/tags?post=2512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}